missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Cleavage stimulation factor 2 Antibody, Novus Biologicals™
Rabbit Polyclonal Antibody
Marque: Novus Biologicals NB100-57531
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
Cleavage stimulation factor 2 Polyclonal specifically detects Cleavage stimulation factor 2 in Human, Mouse samples. It is validated for Western Blot, Immunohistochemistry, Immunoprecipitation, Immunohistochemistry-Paraffin.
Spécification
| Cleavage stimulation factor 2 | |
| Polyclonal | |
| Unconjugated | |
| TBS and 0.1% BSA with 0.09% Sodium Azide | |
| betaCstF-64 variant 2, CF-1 64 kDa subunit, Cleavage stimulation factor 64 kDa subunit, cleavage stimulation factor subunit 2, cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kD, cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa, CSTF 64 kDa subunit, CstF-64 | |
| Rabbit | |
| Affinity Purified | |
| RUO | |
| 1478 | |
| Human, Mouse | |
| IgG |
| Western Blot, Immunohistochemistry, Immunoprecipitation, Immunohistochemistry (Paraffin) | |
| 0.2 mg/mL | |
| Western Blot -2146826273, Immunohistochemistry 1:100 - 1:500, Immunoprecipitation 2-5 mcg/mg, Immunohistochemistry-Paraffin 1:10-1:500 | |
| NP_001316.1 | |
| CSTF2 | |
| The immunogen recognized by this antibody maps to a region between residue 527 and 577 of human cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa using the numbering given in entry NP_001316.1 (GeneID 1478). | |
| 0.1 mL | |
| Primary | |
| Based on 100% sequence identity, this antibody is predicted to react with Rat, X. laevis, X. tropicalis, Chicken, Turkey, Bovine, Dog, Horse, Rabbit, Guinea pig_10141, Pig, Panda, Orangutan, Rhesus Monkey, Gorilla, Chimpanzee, White-tufted-ear marmoset, Chinese hamster, and Naked mole rat. | |
| Store at 4C. Do not freeze. |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
For Research Use Only
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu